Observational studyAnnals of surgical oncology2026
RADar Reflector LocalisatIOn-SCOUT
Observational study in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT05963464 (RADIOSO MILAN I), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
RADIOSO MILAN I (RADar Reflector localisatiOn-SCOUT for carcinOma Mammae, the MILAN IEO Experience I)
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNon-palpable breast cancer lesions can be treated with breast-conserving surgery, for which precise localization of lesions is key. Many localization techniques are available, but all have limitations. The European Institute of Oncology designed the RADIOSO Milan Trial to evaluate the clinical impact of SCOUT
methodsRADIOSO was a single-center, prospective, observational study that enrolled patients with histologically confirmed non-palpable breast lesions eligible for breast-conserving surgery. Respective surveys were used to evaluate patient, radiologist, and surgeon satisfaction with the clinical impact of SCOUT
resultsA total of 298 patients were enrolled after giving informed consent; 254 were included in the final study analysis. The reflector was placed and removed successfully in all cases. In 16% of cases, the reflector was placed during the biopsy, improving patient workflow. In total, 98% of radiologists, 89.8% of surgeons, and 91.8% of patients declared themselves satisfied with the use of SCOUT
conclusionsSCOUT CLINICAL
trial registrationNCT05963464.
Indexed as
Identifiers
41721162What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.